Get the Stockscreener App
8.1967
2.27%
0.182
Pre-market:
8.20
0.0033
+0.04%
Femto Technologies Inc stock is traded at $8.1967, with a volume of 3,953.
It is up +2.27% in the last 24 hours and up +1.82% over the past month.
Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.
See More
Previous Close:
$8.0147
Open:
$8.01
24h Volume:
3,953
Relative Volume:
0.14
Market Cap:
$5.20M
Revenue:
$797.30K
Net Income/Loss:
$-13.61M
P/E Ratio:
-134.59
EPS:
-0.0609
Net Cash Flow:
$-2.85M
1W Performance:
+2.46%
1M Performance:
+1.82%
6M Performance:
-59.48%
1Y Performance:
-99.75%
1-Day Range:
$8.00
$8.1967
1-Week Range:
$7.80
$8.28
52-Week Range:
$7.80
$3,682.20
Femto Technologies Inc Stock (BCAN) Company Profile
Name
Femto Technologies Inc
Sector
Industry
Phone
-
Address
-
Compare BCAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| BCAN | 8.1967 | 5.20M | 797.30K | -13.61M | -2.85M | -0.0609 |
| CRM | 325.70 | 309.29B | 36.47B | 5.63B | 11.46B | 1.59 |
| SAP | 235.02 | 271.00B | 36.09B | 2.98B | 7.67B | 5.2918 |
| NOW | 1,022.98 | 209.86B | 10.46B | 1.34B | 3.35B | 7.72 |
| INTU | 650.60 | 180.93B | 16.29B | 2.96B | 4.63B | 8.44 |
| UBER | 69.60 | 146.00B | 41.96B | 4.40B | 5.96B | -0.22 |
Femto Technologies Inc Stock (BCAN) Latest News
ULVAC Launches Technology Center PYEONGTAEK for Next-Gen Semiconductor Manufacturing Equipment in South Korea - JCN Newswire
Introducing the World's First Rugged Rel 17 5G + Wi-Fi 7 Mobile Hotspot: Sonim H700 Debuts at Telstra - JCN Newswire
NEC launches new end to end private 5G solution with Cisco - japancorp.net
EduEdge Introduces Formula-Style Method, Changing English Mastery for Struggling Students - japancorp.net
TOYOTA GAZOO Racing to Exhibit Immersive Content at Super Taikyu Series 2024 Final Fuji - japancorp.net
Fujitsu and Toyota Systems Corporation achieve 50% reduction in core system update time using generative AI - japancorp.net
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' - japancorp.net
DIFC continues to drive global action in shaping greener economiesAnnounces 2nd edition of the Future Sustainability Forum in Dubai - japancorp.net
Foodrella Tteokbokki Captivates Global Taste Buds - japancorp.net
Valuufy appoints Dr Sachio Semmoto to Chairman of the Board, Signaling a New Era in Sustainability Assessment - japancorp.net
GJK Facility Services Hosts Educational Session With Dr. Chantel Thornton During Breast Cancer Awareness Week - japancorp.net
Femto Technologies Inc. Announces Consolidation of Enhanced Voting Preference Shares - ACN Newswire
HEROWORKS to Participate in TTA 2024, Initiating Comprehensive Expansion into the Singapore Market - JCN Newswire
Canyon Network Secures $6 Million at $60M Valuation for Its Onchain AI Oracle - JCN Newswire
Is Sample Integrity Assessment for Long-read Sequencing Technologies Essential? - SelectScience
BYND Cannasoft Enterprises (NASDAQ:BCAN) versus eGain (NASDAQ:EGAN) Critical Review - Defense World
DENSO Announces Changes of Executive Responsibility and Executive Officers - JCN Newswire
GA-ASI Adds NIDV and NATO DIANA to Blue Magic Netherlands Agenda - JCN Newswire
BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) Short Interest Update - Defense World
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.16% - MSN
Mazda to open new R&D office in Azabudai Hills in early summer 2025 - JCN Newswire
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down to $11.90 - Defense World
Market Insights: FibroGen Inc (FGEN)’s Notable Drop of -1.78, Closing at 0.41 - The Dwinnex
Investing in Fortress Biotech Inc (FBIO) Is Getting More Attractive - Knox Daily
Cantor Fitzgerald Lowers 4D Molecular Therapeutics (NASDAQ:FDMT) to Neutral - MarketBeat
Is FibroGen Inc (FGEN) a threat to investors? - US Post News
Magnetar Financial LLC Increases Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Ferovinum Raises £17.5M in Series A Funding - FinSMEs
Femsa stock downgraded as cash-back falls short despite divestments, says JPMorgan - Investing.com Australia
Femsa downgraded to Neutral from Overweight at JPMorgan - TipRanks
Fortune Brands Innovations, Inc. (NYSE:FBIN) is Teca Partners LP's 3rd Largest Position - MarketBeat
Fletcher Building Initiates Trading Halt for Capital Raise - TipRanks
Baupost Group LLC MA Grows Stock Holdings in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
4D Molecular Therapeutics Inc [FDMT] Records 200-Day SMA of $22.26 - Knox Daily
First Eagle Investment Management LLC Buys 108,500 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World
Ferovinum secures £17.5m in Series A - FinTech Global
Analyzing Ratios: Fomento Economico Mexicano S.A.B. de C.V. ADR (FMX)’s Financial Story Unveiled - The Dwinnex
Fedbank Financial Services allots 1.32 lakh equity shares under ESOS - Business Standard
A new trading data show 4D Molecular Therapeutics Inc (FDMT) is showing positive returns. - SETE News
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh - StreetInsider.com
4D Molecular Therapeutics Inc [FDMT] Revenue clocked in at $21.99 million, down -33.37% YTD: What’s Next? - The DBT News
Ferovinum secures £17.5m for global expansion - The Spirits Business
4D Molecular Therapeutics (NASDAQ:FDMT) Price Target Increased to $39.00 by Analysts at Chardan Capital - Defense World
Ferrum Health Raises $16M in Series A Funding - FinSMEs
Epic Global rebrands as Feenix - Sport for Business
Ferovinum secures £17.5M Series A for wine and spirits platform - Tech.eu
Funding platform Ferovinum raises £17.5m for global expansion, having provided £114m to grow the UK wine and spirits industry - Fintech Alliance
Ferrum Health nabs $16M to get FDA-cleared AI into hospitals - Axios
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate - Yahoo Finance
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 14.4% - MarketBeat
4D Molecular Therapeutics (NASDAQ:FDMT) Given New $39.00 Price Target at Chardan Capital - MarketBeat
Femto Technologies Inc Stock (BCAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.05%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):